Stockreport

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split [Financial Post (Toronto, Ontario, Canada)]

Neoleukin Therapeutics, Inc.  (NLTX) 
PDF biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its Board of Directors (“Boa [Read more]